New ‘universal vaccine’ technology could protect us from future virus outbreaks
Researchers from the University of Cambridge and DIOSynVax have reported successful early clinical trial results for a universal coronavirus vaccine. The vaccine was found to be safe with no significant side effects in human participants.
Why it matters
Universal vaccine technology could provide a proactive defense against future pandemic threats.
The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side-effects. The trial, involving 39 heal... [6203 chars]
The report is a straightforward summary of scientific research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in